Page last updated: 2024-09-05

erlotinib hydrochloride and Cardiomyopathy, Dilated

erlotinib hydrochloride has been researched along with Cardiomyopathy, Dilated in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Chabot, G; Hureaux, J; Pinquié, F; Urban, T	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Cardiomyopathy, Dilated

Article	Year
Maintenance Treatment by Erlotinib and Toxic Cardiomyopathy: A Case Report. Oncology, 2016, Volume: 90, Issue:3 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bundle-Branch Block; Carcinoma, Non-Small-Cell Lung; Cardiomyopathy, Dilated; Cisplatin; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Maintenance Chemotherapy; Pacemaker, Artificial; Pemetrexed; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Stroke Volume; Treatment Outcome	2016

Article

Year

Maintenance Treatment by Erlotinib and Toxic Cardiomyopathy: A Case Report.

Oncology, 2016, Volume: 90, Issue:3

Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bundle-Branch Block; Carcinoma, Non-Small-Cell Lung; Cardiomyopathy, Dilated; Cisplatin; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Maintenance Chemotherapy; Pacemaker, Artificial; Pemetrexed; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Stroke Volume; Treatment Outcome

2016